We are live on ! Find out more
PCM

Portolan Capital Management Portfolio holdings

AUM $1.88B
1-Year Est. Return 115.74%
This Fund
S&P 500
This Quarter Est. Return
+3.68%
1 Year Est. Return
+115.74%
3 Year Est. Return
+581.85%
5 Year Est. Return
+1,047.01%
10 Year Est. Return
+13,266.68%
AUM
$1.07B
AUM Growth
-$59.4M
Cap. Flow
-$20M
Cap. Flow %
-1.87%
Top 10 Hldgs %
31.2%
Holding
149
New
29
Increased
40
Reduced
54
Closed
26

Top Buys

Rank Stock Value
1
CLS icon
Celestica
CLS
+$20.2M
2
CCOI icon
Cogent Communications
CCOI
+$15.8M
3
KOS icon
Kosmos Energy
KOS
+$14.5M
4
WEX icon
WEX
WEX
+$11.4M
5
UTHR icon
United Therapeutics
UTHR
+$11M

Sector Composition

Rank Sector Weight
1 Technology 36.95%
2 Healthcare 16.34%
3 Industrials 9.92%
4 Consumer Discretionary 8.63%
5 Communication Services 8.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CECO icon
101
Ceco Environmental
CECO
$4.14B
$2.62M 0.24%
+163,953
New +$2.24M
QNST icon
102
QuinStreet
QNST
$1.21B
$2.53M 0.24%
+282,171
New +$2.61M
DOUG icon
103
Douglas Elliman
DOUG
$162M
$2.51M 0.24%
1,112,465
-34,514
-3% -$79.3K
MIDD icon
104
Middleby
MIDD
$6.08B
$2.29M 0.21%
+17,872
New +$2.54M
ALTG icon
105
Alta Equipment Group
ALTG
$245M
$2.29M 0.21%
189,478
-22,645
-11% -$339K
RELL icon
106
Richardson Electronics
RELL
$304M
$2.28M 0.21%
208,226
+35,757
+21% +$461K
RPRX icon
107
Royalty Pharma
RPRX
$25.3B
$2.13M 0.2%
78,352
-60,139
-43% -$1.79M
DIBS icon
108
1stdibs.com
DIBS
$171M
$2.02M 0.19%
555,912
-1,655
-0.3% -$6.6K
HBIO icon
109
Harvard Bioscience
HBIO
$29.2M
$1.94M 0.18%
45,090
-33,269
-42% -$1.54M
DOMO icon
110
Domo
DOMO
$184M
$1.74M 0.16%
177,394
-4,526
-2% -$62.9K
MSFT icon
111
Microsoft
MSFT
$3.71T
$1.71M 0.16%
5,425
+8
+0.1% +$2.64K
NTNX icon
112
Nutanix
NTNX
$16.9B
$1.71M 0.16%
49,070
-134,720
-73% -$4.23M
PRTS icon
113
CarParts.com
PRTS
$54.7M
$1.53M 0.14%
37,243
-41,608
-53% -$1.84M
RH icon
114
RH
RH
$3.71B
$1.52M 0.14%
5,748
-2,222
-28% -$773K
TWLO icon
115
Twilio
TWLO
$36.6B
$1.26M 0.12%
21,546
-55,623
-72% -$3.47M
AXTI icon
116
AXT Inc
AXTI
$5.8B
$1.22M 0.11%
509,360
-1,548
-0.3% -$4.09K
CLH icon
117
Clean Harbors
CLH
$16.3B
$1.05M 0.1%
6,247
-15,709
-72% -$2.65M
HIMS icon
118
Hims & Hers Health
HIMS
$7.31B
$944K 0.09%
+150,000
New +$1.12M
VVX icon
119
V2X
VVX
$2.65B
$712K 0.07%
13,780
-100,923
-88% -$5.07M
GOOG icon
120
Alphabet (Google) Class C
GOOG
$4.32T
$528K 0.05%
4,008
+1
+0% +$130
DXLG icon
121
Destination XL Group
DXLG
$35.4M
$446K 0.04%
99,537
-28,156
-22% -$132K
BXC icon
122
BlueLinx
BXC
$706M
$397K 0.04%
4,834
-43,272
-90% -$3.8M
EMKR
123
DELISTED
Emcore Corp
EMKR
$315K 0.03%
66,350
-67,158
-50% -$437K
ANIK icon
124
Anika Therapeutics
ANIK
$287M
-108,632
Closed -$2.82M
ASO icon
125
Academy Sports + Outdoors
ASO
$2.98B
-59,564
Closed -$3.22M

Similar funds

Portolan Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Portolan Capital Management held 149 positions worth $1.07B, down 5.3% from $1.13B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Portolan Capital Management's Q3 2023 filing shows 29 new, 40 increased, 54 reduced and 26 closed positions. Its largest new stake was Cogent Communications: 241,516 shares worth $14.9M. The largest sale was Avid Technology Inc, an estimated $19.9M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Industrials.

  • Portolan Capital Management's largest Q3 2023 buy was Cogent Communications: 241,516 shares worth $14.9M.
  • Portolan Capital Management added most to Celestica in Q3 2023, an estimated $20.2M increase.
  • Portolan Capital Management's biggest Q3 2023 reduction was Kura Sushi USA, cutting an estimated $17.5M.
  • Portolan Capital Management fully exited Avid Technology Inc in Q3 2023, selling an estimated $19.9M.
  • Portolan Capital Management's ten largest holdings make up 31% of its $1.07B portfolio in Q3 2023.
  • Portolan Capital Management opened 29 new positions and closed 26 in Q3 2023.
  • Portolan Capital Management's portfolio value fell 5.3% quarter-over-quarter to $1.07B.

Based on Portolan Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.